HomeELTX • NASDAQ
add
Elicio Therapeutics Inc
Previous close
$9.00
Day range
$8.80 - $9.78
Year range
$2.96 - $24.39
Market cap
91.91M USD
Avg Volume
55.17K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.39M | 57.56% |
Net income | -8.95M | -34.57% |
Net profit margin | — | — |
Earnings per share | -3.78 | — |
EBITDA | -9.30M | -58.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 12.89M | 109.45% |
Total assets | 27.15M | 19.78% |
Total liabilities | 15.77M | 14.72% |
Total equity | 11.37M | — |
Shares outstanding | 10.22M | — |
Price to book | 7.63 | — |
Return on assets | -80.78% | — |
Return on capital | -124.26% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -8.95M | -34.57% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2011
Headquarters
Website
Employees
32